Rheumatoid Arthritis, Statin Indication and Lipid Goals: Analysis According to Different Recommendations

Walter Masson1, Emiliano Rossi1, Rodolfo N Alvarado2

  • 1Servicio de Cardiología, Hospital Italiano de Buenos Aires, Tte. Gral. Juan Domingo Perón 4190, C1199ABB Ciudad Autónoma de Buenos Aires, Argentina.

Reumatologia Clinica
|March 22, 2021
PubMed

Insights

Cardiovascular risk in rheumatoid arthritis (RA) patients varies by strategy, with significant gaps in statin therapy and LDL-C goal achievement. Different guidelines yield different statin indications for RA patients.

Area of Science:

  • Cardiology
  • Rheumatology
  • Public Health

Background:

  • Cardiovascular disease (CVD) is a major concern for patients with rheumatoid arthritis (RA).
  • Effective cardiovascular risk management strategies are crucial for RA patients.
  • Current guidelines offer various approaches to managing cardiovascular risk in RA.

Purpose of the Study:

  • To compare different cardiovascular risk assessment strategies in RA patients.
  • To determine the proportion of RA patients eligible for statin therapy under various guidelines.
  • To evaluate the achievement of lipid goals in RA patients based on European recommendations.

Main Methods:

  • A cross-sectional study utilizing a secondary database.
  • Estimation of cardiovascular risk using QRISK-3, Framingham, ASCVD, and SCORE calculators.
  • Analysis of statin therapy indications based on NICE, Argentine Consensus, ACC/AHA, and European guidelines.

Main Results:

  • Different guidelines resulted in varying eligibility for statin therapy (18.2%–41.1%).
  • Only 24.7% (primary) and 48.7% (secondary) prevention patients were on statins.
  • Under European guidelines, 50.0%, 46.2%, and 15.9% of low-moderate, high, and very high-risk patients met lipid goals, respectively.

Conclusions:

  • Cardiovascular risk stratification and statin indication differ significantly across the four analyzed strategies in RA patients.
  • A notable discrepancy exists between recommended and actual statin use.
  • Few RA patients achieve their target LDL-C goals, highlighting a need for improved lipid management.
Abstract

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.1K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
102
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
113
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
116
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
456
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
124